Figure 3.
(A) MRI scan of the same patient at baseline and (B) at 24 weeks, following therapy with teprotumumab (red arrows indicate extraocular muscles)
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.